AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CANbridge Pharmaceuticals Inc.

HKD 1.91 -$0.45 (-19.28%)
HKSE · 16 Sep 2026 02:16 UTC
Previous Close
HKD 1.87
Day Range
HKD 1.79HKD 1.91
Year Range
HKD 1.61HKD 3.5
Market Cap
809.32M
AVG Volume
1.57M
Trailing/Forward PE
-10.32/-
PEG ratio
0.83
Dividend Yield
-
Next Earnings Date
2027-04-01
Primary Exchange
Hong Kong Stock ExchangeHK
Revenue (CNY)
050M100M150M202020212022202320242025
1228.HK Revenue (CNY) by year
PeriodRevenue (CNY)
202549.98M
202485.1M
2023102.87M
202278.97M
202131.16M
202012.03M
Net Income (CNY)
-1.5B-1B-500M0500M202020212022202320242025
1228.HK Net Income (CNY) by year
PeriodNet Income (CNY)
202514.82M
2024-442.62M
2023-378.84M
2022-483.48M
2021-1.08B
2020-846.04M
Operating Income (CNY)
-800M-600M-400M-200M0202020212022202320242025
1228.HK Operating Income (CNY) by year
PeriodOperating Income (CNY)
2025-92.7M
2024-340.51M
2023-366.55M
2022-457.97M
2021-655.15M
2020-231.49M
EBITDA (CNY)
-800M-600M-400M-200M0202020212022202320242025
1228.HK EBITDA (CNY) by year
PeriodEBITDA (CNY)
2025-79.66M
2024-328.11M
2023-354.72M
2022-448.84M
2021-646.11M
2020-217.13M
Cash Flows (CNY)
-600M-400M-200M0202020212022202320242025
1228.HK Cash Flows (CNY) by year
PeriodCash Flows (CNY)
2025-38.22M
2024-122.5M
2023-283.38M
2022-296.18M
2021-592.16M
2020-154.22M
EPS (CNY)
-15-10-505202020212022202320242025
1228.HK EPS (CNY) by year
PeriodEPS (CNY)
20250.05
2024-1.04
2023-0.9
2022-1.14
2021-11.06
2020-12.32
Expenses (CNY)
0200M400M600M800MR&DSG&ACapex202020212022202320242025
1228.HK Expenses (CNY) by year
PeriodExpenses (CNY)
2025129.26M
2024394.92M
2023435.86M
2022522.06M
2021679.01M
2020240.94M
Cash & Debt (CNY)
0200M400M600M800MCashLong Term DebtShort Term Debt202020212022202320242025
1228.HK Cash & Debt (CNY) by year
PeriodCash & Debt (CNY)
202566.62M
202410.5M
2023137.49M
2022451.16M
2021745.82M
2020360.8M
Debt ratios
-0.1-0.0500.05202320242025
1228.HK Debt ratios by year
PeriodDebt ratios
20250.04
2024-0.07
2023-0
Margins
0%20%40%60%80%202020212022202320242025
1228.HK Margins by year
PeriodMargins
202573.13%
202463.81%
202362.37%
202261.91%
202160.25%
202057.16%
Return on Capital
-500%0%500%1000%202020212022202320242025
1228.HK Return on Capital by year
PeriodReturn on Capital
2025-4.34%
202493.28%
2023952.14%
2022-156.69%
2021-155.32%
202048.46%
Shares Outstanding
0200M400M600M202020212022202320242025
1228.HK Shares Outstanding by year
PeriodShares Outstanding
2025477.04M
2024424.83M
2023424.45M
2022424.23M
2021114.92M
202068.68M
Book Value Per Share (CNY)
-30-20-10010202020212022202320242025
1228.HK Book Value Per Share (CNY) by year
PeriodBook Value Per Share (CNY)
2025-0.72
2024-1.12
2023-0.09
20220.73
20216.03
2020-25.42
Total Assets (CNY)
0250M500M750M1B202020212022202320242025
1228.HK Total Assets (CNY) by year
PeriodTotal Assets (CNY)
2025165.39M
2024116.81M
2023395.36M
2022702.04M
2021892.52M
2020586.36M
PE Ratio
50607080med 56.43Apr 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
1228.HK PE Ratio by year
PeriodPE Ratio
Sep 2651.49
Sep 2652.32
Sep 2652.91
Aug 2655.79
Aug 2657.4
Aug 2656.14
Aug 2663.13
Jul 2655.15
Jul 2656.99
Jul 2657.32
Jul 2656.49
Jul 2655.1
Jun 2655.82
Jun 2655.33
Jun 2655.29
Jun 2655.05
May 2656.43
May 2655.56
May 2660.75
May 2664.32
Apr 2658.65
Apr 2667.97
Apr 2674.26
Apr 2676.35
Apr 2677.77
Free Cash Flow Yield
-600%-400%-200%0%med -4.97%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
1228.HK Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-5.01%
Sep 26-4.93%
Sep 26-4.87%
Aug 26-4.62%
Aug 26-4.49%
Aug 26-4.59%
Aug 26-4.09%
Jul 26-4.68%
Jul 26-4.53%
Jul 26-4.5%
Jul 26-4.57%
Jul 26-4.68%
Jun 26-4.62%
Jun 26-4.66%
Jun 26-4.66%
Jun 26-4.69%
May 26-4.57%
May 26-4.64%
May 26-4.25%
May 26-4.01%
Apr 26-4.4%
Apr 26-3.79%
Apr 26-3.47%
Apr 26-3.38%
Apr 26-3.32%
Mar 26-2.78%
Mar 26-2.74%
Mar 26-2.81%
Mar 26-2.68%
Feb 26-2.5%
Feb 26-2.74%
Feb 26-2.6%
Feb 26-2.34%
Jan 26-2.6%
Jan 26-3.11%
Jan 26-3.11%
Jan 26-3.22%
Jan 26-3.03%
Dec 25-2.62%
Dec 25-3.12%
Dec 25-2.73%
Dec 25-2.52%
Nov 25-2.87%
Nov 25-3.09%
Nov 25-3.17%
Nov 25-3.27%
Oct 25-3%
Oct 25-3.21%
Oct 25-2.75%
Oct 25-2.41%
Oct 25-2.19%
Sep 25-7.95%
Sep 25-7.37%
Sep 25-7.06%
Sep 25-7.64%
Aug 25-8.07%
Aug 25-7.53%
Aug 25-10.2%
Aug 25-13.86%
Aug 25-23.9%
Jul 25-24.04%
Jul 25-25.3%
Jul 25-25.34%
Jul 25-54.39%
Jun 25-112.71%
Jun 25-95.81%
Jun 25-96.97%
Jun 25-211.23%
May 25-230.89%
May 25-236.5%
May 25-226.46%
May 25-229.58%
May 25-224.32%
Apr 25-216.18%
Apr 25-210.01%
Apr 25-175.2%
Apr 25-213.9%
Mar 25-266.87%
Mar 25-305.1%
Mar 25-305.56%
Mar 25-276.25%
Feb 25-238.06%
Feb 25-282.84%
Feb 25-321.31%
Feb 25-313.03%
Jan 25-293.24%
Jan 25-347.77%
Jan 25-288.15%
Jan 25-355.05%
Jan 25-327.93%
Dec 24-393.3%
Dec 24-372.71%
Dec 24-354.44%
Dec 24-341.64%
Nov 24-438.37%
Nov 24-354.01%
Nov 24-263.54%
Nov 24-231.97%
Nov 24-215.92%
Oct 24-232.78%
Price to Sales
0102030med 12.33Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
1228.HK Price to Sales by year
PeriodPrice to Sales
Sep 2615.27
Sep 2615.51
Sep 2615.69
Aug 2616.54
Aug 2617.02
Aug 2616.64
Aug 2618.72
Jul 2616.35
Jul 2616.9
Jul 2616.99
Jul 2616.75
Jul 2616.34
Jun 2616.55
Jun 2616.4
Jun 2616.39
Jun 2616.32
May 2616.73
May 2616.47
May 2618.01
May 2619.07
Apr 2617.39
Apr 2620.15
Apr 2622.02
Apr 2622.64
Apr 2623.06
Mar 2619.6
Mar 2619.82
Mar 2619.34
Mar 2620.33
Feb 2621.78
Feb 2619.86
Feb 2620.9
Feb 2623.27
Jan 2620.97
Jan 2617.49
Jan 2617.5
Jan 2616.92
Jan 2617.96
Dec 2514.03
Dec 2511.8
Dec 2513.48
Dec 2514.62
Nov 2512.84
Nov 2511.91
Nov 2511.6
Nov 2511.26
Oct 2512.25
Oct 2511.45
Oct 2513.4
Oct 2515.25
Oct 2516.84
Sep 2512.4
Sep 2513.38
Sep 2513.96
Sep 2512.9
Aug 2512.21
Aug 2513.09
Aug 259.66
Aug 257.11
Aug 254.12
Jul 254.1
Jul 253.89
Jul 253.89
Jul 251.81
Jun 251.28
Jun 251.5
Jun 251.48
Jun 250.68
May 250.62
May 250.61
May 250.64
May 250.63
May 250.64
Apr 250.67
Apr 250.69
Apr 250.82
Apr 250.67
Mar 250.67
Mar 250.59
Mar 250.59
Mar 250.65
Feb 250.75
Feb 250.64
Feb 250.56
Feb 250.57
Jan 250.61
Jan 250.52
Jan 250.62
Jan 250.51
Jan 250.55
Dec 240.53
Dec 240.56
Dec 240.59
Dec 240.61
Nov 240.48
Nov 240.59
Nov 240.79
Nov 240.9
Nov 240.97
Oct 240.9
Price to Book
0246med 2.36Apr 22Jul 22Oct 22Feb 23May 23Sep 23Dec 23
1228.HK Price to Book by year
PeriodPrice to Book
Dec 233.36
Dec 232.32
Dec 232.55
Dec 233.05
Nov 233.25
Nov 233.82
Nov 234.52
Nov 234.52
Oct 234.53
Oct 234.63
Oct 234.72
Oct 234.55
Sep 234.55
Sep 234.43
Sep 234.7
Sep 234.82
Sep 235.09
Aug 235.4
Aug 235.24
Aug 235.38
Aug 235.05
Jul 235.17
Jul 235.21
Jul 235.28
Jul 235.14
Jun 235.18
Jun 232.09
Jun 231.97
Jun 232.2
Jun 232.24
May 231.73
May 231.84
May 231.95
May 231.82
Apr 232.29
Apr 232.37
Apr 232.43
Apr 232.43
Mar 232.43
Mar 232.5
Mar 232.51
Mar 232.6
Mar 232.67
Feb 232.8
Feb 232.83
Feb 232.86
Feb 232.91
Jan 232.86
Jan 232.92
Jan 232.91
Jan 233.02
Dec 222.98
Dec 221.84
Dec 221.87
Dec 221.91
Dec 221.92
Nov 222
Nov 222.09
Nov 221.63
Nov 222.05
Oct 222.13
Oct 222.16
Oct 222
Oct 222.2
Sep 222.26
Sep 222.2
Sep 222.38
Sep 222.51
Sep 221.46
Aug 221.99
Aug 222.36
Aug 222.34
Aug 222.4
Jul 222.54
Jul 222.65
Jul 222.69
Jul 222.71
Jun 222.86
Jun 220.54
Jun 220.55
Jun 220.62
Jun 220.58
May 220.59
May 220.6
May 220.64
May 220.62
Apr 220.63
Apr 220.58
Apr 220.59
Apr 220.64
Apr 220.78
Mar 220.71
Mar 220.8
Mar 220.76
Mar 220.81
Feb 220.8
Feb 220.85
Feb 220.98
Feb 220.99
Jan 221.01
CANbridge Pharmaceuticals Inc.
1228.HK
Stockpicker

Video analysis: 1228.HK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.